Company Name:MyoKardia Inc.
CEO: Anastasios Gianakakos

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: MyoKardia Inc is a clinical stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.


Key numbers

Market Capitalization:3190056260
Shares Outstanding: 46226000
Float: 44053702
Next Earning Date:2020-03-05
TTm EPS: -5.2168
TTm Dividend Rate:
200 days moving average:55.76
50 days moving average: 67.44
One day percent Change: 0.07



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,